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Abstract
In this paper we aim to provide insight into the complexity of outbreak management in an intensive care unit (ICU) setting. In October
2010 four patients on the ICU of our tertiary care centre were colonized or infected with a multidrug-resistant strain of Pseudomonas
aeruginosa (MDR-PA). An outbreak investigation was carried out and infection control measures were taken in an attempt to identify a
potential source and stop transmission. The outbreak investigation included descriptive epidemiology, comprising retrospective case
ﬁnding by reviewing the laboratory information system back to 2004 and prospective case ﬁnding by patient screening for MDR-PA.
Furthermore, microbiological analysis, environmental screening and a case-control study were carried out. Infection control measures
consisted of re-education of healthcare personnel on basic hygiene measures, auditing of hygiene procedures used in daily practice by
infection control practitioners, and stepwise up-regulation of isolation measures. From February 2009 to January 2012, 44 patients on
our ICU were found to be MDR-PA positive. MDR-PA isolates of the 44 patients showed two distinct AFLP patterns, with homology
within each of the AFLP clusters of more than 93%. The VIM metallo-b-lactamase gene was detected in 20 of 21 tested isolates. A
descriptive epidemiology investigation identiﬁed the rooms with the highest numbers of MDR-PA positive patients. The case-control
study showed three factors to be independently associated with MDR-PA positivity: admission to ICU subunit 1 (OR, 6.1; 95% CI, 1.7,
22), surgery prior to or during admission (OR, 5.7; 95% CI, 1.6, 20) and being warmed-up with the warm-air blanket (OR, 3.6; 95% CI,
1.2, 11). After three environmental screening rounds, with sampling of sinks, furniture and devices in the ICU, without revealing a clear
common source, a fourth environmental investigation included culturing of faucet aerators. Two faucets were found to be positive for
MDR-PA and were replaced. The occurrence of new cases decreased with the strengthening of infection control measures and
declined further with the removal of the common source. With this integrated approach a prolonged outbreak of P. aeruginosa was
controlled. Contaminated faucet aerators on the ICU probably served as a persisting source, while interpatient transmission by medical
staff was a likely way of spread. Seven months after the last case (January 2012) and 3 months after cessation of extended isolation
measures (May 2012), single cases started to occur on the ICU, with a total of seven patients in the past year. No common source has
yet been found.
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Abstract
The aim of this work was to describe national surveillance of invasive beta-haemolytic streptococci (BHS) in Denmark and to report overall
trends and major ﬁndings by groups and types of BHS causing laboratory-conﬁrmed disease from 2005 to 2011. A total of 3063 BHS isolates
were received from 2872 patients. Based on conﬁrmed cases the overall annual incidence increased from 6.2 to 8.9 per 100 000 persons
between 2005 and 2011. In 2011 the incidences of group A, B, C and G streptococci were 3.1, 2.3, 0.9 and 2.6 per 100 000 persons,
respectively. An increase was observed for all groups of BHS, but in particular for group G in men above 65 years of age. Among group A
streptococci (GAS), ﬁve T-types (1, 28,12, 3,13,B3264 and B3264) represented 71% and ﬁve emm-types (1, 28, 3, 89 and 12) 76% of all
isolates. Among group B streptococci (GBS) four types (III, Ia, V, Ib) represented 79% of the isolates. Potential coverage for future vaccines
against GAS and GBS disease was 76% compared with the 26-valent GAS vaccine and 89% based on GBS serotypes Ia, Ib, II, III and V. The
number of reported cases of invasive BHS disease increased in Denmark from 2005 to 2011. Nationwide laboratory-based surveillance of
BHS is required to monitor epidemiological changes, explore potential outbreaks and determine potential vaccine coverage.
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Abstract
Over the past 5 years, a number of cases of legionellosis in Scotland have been associated with compost use; however, studies investigating
sources of infection other than water systems remain limited. This study delivers the ﬁrst comprehensive survey of composts commonly
available in the UK for the presence of Legionella species. Twenty-two store-bought composts, one green-waste compost and one
home-made compost were tested for Legionella by culture methods on BCYE-a medium, and the ﬁndings were conﬁrmed by macrophage
infectivity potentiator (mip) speciation. Twenty-two of the samples were retested after an enrichment period of 8 weeks. In total, 15 of 24
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composts tested positive for Legionella species, a higher level of contamination than previously seen in Europe. Two isolates of Legionella
pneumophila were identiﬁed, and Legionella longbeachae serogroup 1 was found to be one of the most commonly isolated species.
L. longbeachae infection would not be detected by routine Legionella urinary antigen assay, so such testing should not be used as the sole
diagnostic technique in atypical pneumonia cases, particularly where there is an association with compost use. The occurrence of Legionella
in over half of the samples tested indicates that compost could pose a public health risk. The addition of general hygiene warnings to
compost packages may be beneﬁcial in protecting public health.
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Abstract
New diagnostics and vaccines for tuberculosis (TB) are urgently needed, but require an understanding of the requirements for protection
from/susceptibility to TB. Previous studies have used unbiased approaches to determine gene signatures in single-site populations. The
present study utilized a targeted approach, reverse transcriptase multiplex ligation-dependent probe ampliﬁcation (RT-MLPA), to validate
these genes in a multisite study. We analysed ex vivo whole blood RNA from a total of 523 participants across four sub-Saharan countries
(Ethiopia, Malawi, South Africa, and The Gambia) with differences in TB and human immunodeﬁciency virus (HIV) status. We found a
number of genes that were expressed at signiﬁcantly lower levels in participants with active disease than in those with latent TB infection
(LTBI), with restoration following successful TB treatment. The most consistent classiﬁer of active disease was FCGR1A (high-afﬁnity IgG Fc
receptor 1 (CD64)), which was the only marker expressed at signiﬁcantly higher levels in participants with active TB than in those with LTBI
before treatment regardless of HIV status or genetic background. This is the ﬁrst study to identify a biomarker for TB that is not affected by
HIV status or geo-genetic differences. These data provide valuable clues for understanding TB pathogenesis, and also provide a
proof-of-concept for the use of RT-MLPA in rapid and inexpensive validation of unbiased gene expression ﬁndings.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, 315–317
CMI Online-Only Abstracts 317
